One of the most widely investigated ROCK inhibitors is Y-27632 (47), which is a selective small inhibitor of both ROCK1 and ROCK2 that suppresses the invasiveness and metastasis of rat and human hepatoma cells, bladder cancer cells, colorectal cancer cells, lung cancer cells, and cancer cell types (48–53). Here, ROCK2 is linked to colorectal cancer.